About TONACEA
Tonacea is a premier ecosystem platform in China's biopharmaceutical innovation sector. With over two decades of deep engagement in new drug development, it has evolved into a central hub driving China's pharmaceutical innovation force.
The platform brings together multinational pharmaceutical companies, Biotech firms, investment institutions, research institutes, and regulatory experts, building an elite network and knowledge-sharing system that covers the entire R&D value chain. Its business spans industry summits, technical forums, corporate training, media communications, and strategic consulting. With branch offices in Beijing, Shanghai, Suzhou, Guangzhou, and Shenzhen, it has established a nationwide operational network.
Tonacea's WeChat official account and video channel consistently deliver in-depth industry research, with viewpoints frequently cited by capital markets and media, becoming widely recognized as an "authoritative source" in the industry. The "Huashan Award," jointly presented by the platform, sets an international benchmark for Chinese innovative drugs and promotes local companies onto the global stage.
In 2026, Tonacea is strategically upgrading. On July 22-24, it will launch the "China's JPM" — the inaugural China Pharma Innovation Conference (CPIC) — at the National Exhibition and Convention Center (Shanghai). The conference will be held at the world's largest exhibition complex and permanent venue for the China International Import Expo (CIIE). Leveraging the four-dimensional transportation network of the Hongqiao International Hub, CPIC will systematically invite multinational pharmaceutical companies, international investment banks, global capital, and professional service institutions to gather in Shanghai, delve into the Yangtze River Delta — the birthplace of China's innovative drugs — and engage in in-depth exchanges and one-on-one business matchmaking with over a thousand outstanding enterprises. This will establish a new global pattern for innovative drugs: "San Francisco in early year, Shanghai in mid-year," continuously connecting Chinese innovation to the world and amplifying its value. More>>
Since TONACEA established in 2004, We have held more than 120 professional forums. At the same time, TONACEA has been invited to plan and operate annual biomedical industry innovation conferences for governments in Suzhou, Wuxi, Beijing, Shenzhen, Guangzhou, Zhengzhou and other places. Thematic training such as "Consistency of Generic Drugs", "File simultaneously in China and the United States", "Valuation of Novel Drugs" and "Clinical case analysis" have become classic training activities in the industry. Continuous accumulation has also resulted in the annual industry brand conference of TONACEA "Global Conference on Biopharma Frontier Technology ".
At the beginning of 2020, TONACEA will create a series of brand activities called "TONACEA President Meeting Room", bringing together the CEOs/ presidents of member institutions to enjoy the landscape and build the Co-founding Tech-life， together arrive at a poetric future of Chinese novel drugs.
Journy
Together arrive at a poetric future of Chinese novel drugs
Since 2013, based on the "Highland of China's Novel drug thought", TONACEA has started to build a new media matrix, and has carried out multi-level reports on frontier technology, policies and regulations, capital markets, industrial transformation, innovative figures and other bio-innovation related fields. At present, TONACEA continues to serve more than 500 customers.
On wechat, TONACEA accounts have accumulated more than 300,000 subscribers, mainly including leaders of government, parks, listed companies, innovative pharmaceutical enterprises, investment institutions, and front-line practitioners. In addition, TONACEA has entered community platforms such as Snowball, Zhihu and Weibo. TONACEA's brand exposure has exceeded 24 million.
XIEYI Live Stream continues to launch forum in the cloud. It provides an online way to gain insight into the industry dynamics in the first time, to lead the industry and empower enterprises.
XIEYI Live Stream is committed to providing one-stop service solutions for Chinese biomedical enterprises. It covers a variety of types, such as conferences with more than thousands of people, personal interview, promotion and release, XIEYI live class and so on.
The platform has strong advantages: top experts, first class; XIEYI planning, high level; Media matrix, full-line promotion and distribution; Professional hosting, warm service; Wechat community, targeted promotion; Standardized process, professional technology. TONACEA can provide whole-process control before, during and after live broadcasting.
Provide service for more than 200 institutions
Operate with governmental parks
BioBay – Suzhou Biomedical Industrial Park
Suzhou Biomedical Industrial Park (BioBay) is located in Suzhou Industrial Park and serves as an innovation hub for cultivating the biomedical industry in the region.
Suzhou Wuzhong Biomedical Industrial Park is one of the first batch of municipal-level biomedical industrial parks in Suzhou.
Zhengzhou Airport Biomedical Park makes a ten-year commitment to biomedical enterprises: to build a new industrial highland in Central China together.
Recommendation
CPIC 2026丨Agenda Released! North America-China Innovative Drug Industry Collaboration Special Session
CPIC 2026 | "Lu Lu" Debuts: The Spirit of the Eastern Unicorn, Empowering Innovation
CPIC 2026 | Heavy Guest Confirmation! Speech by Dr. Kendra Rose, Bayer BD SVP, at the conference
Contact us
Address：Room 305, Building 4, Zone 3, Hanwei International Plaza, Fengtai District, Beijing
Tel：010-83634390
Address：Address：Room 1704, Building E, Nanotechnology Park, SIP, Suzhou, Jiangsu Province
TONACEA
XIEYI Release
TONACEA Biotech
TONACEA Micro Service
©2025 TONACEA（beijing）Technology Development Co., Ltd
About TONACEA
Tonacea is a premier ecosystem platform in China's biopharmaceutical innovation sector. With over two decades of deep engagement in new drug development, it has evolved into a central hub driving China's pharmaceutical innovation force.
The platform brings together multinational pharmaceutical companies, Biotech firms, investment institutions, research institutes, and regulatory experts, building an elite network and knowledge-sharing system that covers the entire R&D value chain. Its business spans industry summits, technical forums, corporate training, media communications, and strategic consulting. With branch offices in Beijing, Shanghai, Suzhou, Guangzhou, and Shenzhen, it has established a nationwide operational network.
Tonacea's WeChat official account and video channel consistently deliver in-depth industry research, with viewpoints frequently cited by capital markets and media, becoming widely recognized as an "authoritative source" in the industry. The "Huashan Award," jointly presented by the platform, sets an international benchmark for Chinese innovative drugs and promotes local companies onto the global stage.
In 2026, Tonacea is strategically upgrading. On July 22-24, it will launch the "China's JPM" — the inaugural China Pharma Innovation Conference (CPIC) — at the National Exhibition and Convention Center (Shanghai). The conference will be held at the world's largest exhibition complex and permanent venue for the China International Import Expo (CIIE). Leveraging the four-dimensional transportation network of the Hongqiao International Hub, CPIC will systematically invite multinational pharmaceutical companies, international investment banks, global capital, and professional service institutions to gather in Shanghai, delve into the Yangtze River Delta — the birthplace of China's innovative drugs — and engage in in-depth exchanges and one-on-one business matchmaking with over a thousand outstanding enterprises. This will establish a new global pattern for innovative drugs: "San Francisco in early year, Shanghai in mid-year," continuously connecting Chinese innovation to the world and amplifying its value.